Monthly Archive for October, 2011

RedHill Biopharma appoints Prof. Colm O’Morain, MD as Lead Investigator for the European Phase III trial with RHB-104 (Crohn’s)

Published on October 25, 2011 in News.

RedHill appoints Prof O’Morain as Lead Investigator for the European Phase III clinical trial with RHB-104 (Crohn’s) Hebrew Redhill appoints Prof O’Morain as Lead Investigator for the European Phase III trial with RHB-104 – Crohn’s (October 24 2011)

Read More...

RedHill Biopharma appoints Prof. David Y. Graham, MD as Lead Investigator for the US pivotal trial with RHB-104 (Crohn’s)

Published on October 6, 2011 in News.

RedHill Biopharma appoints Prof Graham as Lead Investigator for RHB-104 – Crohn’s (Hebrew) (October 5, 2011) RedHill Biopharma appoints Prof Graham as Lead Investigator for the US pivotal trial with RHB-104 – Crohn’s (October 5, 2011)

Read More...